20 articles
New research shows combining weight-loss medications with hormone therapy could transform health outcomes for obese men with low testosterone.
Comprehensive review reveals estrogen-only therapy carries lower breast cancer risk than combined hormone treatments during menopause.
New research reveals why Addison's disease patients face higher mortality despite treatment and explores promising therapeutic approaches.
Research reveals how the steroid hormone pregnenolone allows cancer cells to evade immune detection and reduces immunotherapy effectiveness.
International study shows surgical treatment significantly reduces cardiovascular risks compared to medication alone.
A comprehensive 2025 review framework matches GLP-1 agonists, tirzepatide, and other AOMs to specific obesity phenotypes, complications, and life stages.
20-week study reveals how sequencing HIIT and resistance training affects metabolic health in women with morbid obesity.
University of Pennsylvania researchers investigated how insulin resistance and testosterone interact in women after menopause.
Science-backed protocols for using exercise, circadian eating, and sleep to dramatically improve glucose control and longevity.
New research shows acupuncture significantly reduces insulin resistance and hormone imbalances in PCOS by targeting bile acid pathways.
A major Cochrane network meta-analysis protocol will rank all insulin regimens by efficacy and safety for adults with type 1 diabetes.
A landmark JCI review maps the expanding pharmacological arsenal for MASH, from GLP-1 agonists to triple receptor therapies and precision medicine.
Advanced incretin-based therapies show potential for major weight loss while protecting heart, kidney, liver, and brain health.
Three new NIH-funded findings tackle metabolic aging, cardiovascular risk, and a surprising hormonal brake on brain tumors.
A steroid hormone activates receptor GPR56 to block ferroptosis, a form of iron-driven cell death linked to liver disease.
A mouse study reveals how aging and poor diet synergistically disrupt liver thyroid hormone metabolism, accelerating fatty liver disease — and why resmetirom may help.
New research reveals FGF21 has a physiological role in reducing ER stress by amplifying the unfolded protein response through sulfide signaling.
The triple agonist retatrutide drives deep metabolic shifts beyond weight loss, improving key biomarkers of cardiovascular and insulin health.
Three-month romosozumab protocol offers pragmatic solution for osteoporosis treatment with potentially improved patient outcomes.
New research shows melatonin supplementation during IVF can prevent obesity and glucose problems in offspring by restoring liver function.
